Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Novel <i>GPRC5B</i>::<i>PRKCA</i> gene fusion in an unclassifiable low-grade glioneuronal tumor.

Neuro-oncology advances·2026

Same author

Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8<sup>+</sup> T cell responses and promoting tertiary lymphoid structure formation.

Nature communications·2026

Same author

Preoperative sarcopenia diagnosed based on the asian working group criteria and Short-term outcomes in older patients undergoing resection of early-stage non-small cell lung cancer.

Surgery today·2026

Same author

Prolonged isolated dysgeusia as an initial manifestation of neurolymphomatosis in primary central nervous system lymphoma: illustrative case.

Journal of neurosurgery. Case lessons·2026

Same author

Impact of Pathological Lymphovascular Invasion of Lung Adenocarcinoma after Induction Chemoradiotherapy.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·2026

Same author

Vasoproliferative Retinal Tumor with Hemangioblastoma-like Features: Evaluation with von Wilebrand Factor.

Journal of clinical medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells.

Takahiro Tsuji^1,2, Haruka Hirose³, Daisuke Sugiyama⁴

¹Department of Anatomy and Molecular Cell Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Cancer Research

|December 10, 2025

Summary

This summary is machine-generated.

Researchers uncovered how brain immune cells called microglia respond to early-stage brain metastases. Modulating these microglia may offer new therapeutic strategies for eliminating tumors before they spread.

More Related Videos

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Isolation of Mouse Primary Microglia by Magnetic-Activated Cell Sorting in Animal Models of Demyelination

Isolation of Mouse Primary Microglia by Magnetic-Activated Cell Sorting in Animal Models of Demyelination

Published on: April 5, 2022

Related Experiment Videos

Last Updated: Jun 14, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Isolation of Mouse Primary Microglia by Magnetic-Activated Cell Sorting in Animal Models of Demyelination

Isolation of Mouse Primary Microglia by Magnetic-Activated Cell Sorting in Animal Models of Demyelination

Published on: April 5, 2022

Area of Science:

Neuroscience
Immunology
Oncology

Background:

Brain metastases are a common and fatal outcome of advanced cancers.
Microglia, the brain's immune cells, have complex roles in established tumors, but their early-stage functions are unclear.
Understanding early microglial responses is crucial for developing therapies against nascent brain tumors.

Purpose of the Study:

To investigate the dynamic behavior and heterogeneity of microglial populations during the initial development of brain metastases.
To identify molecular mechanisms regulating microglial phenotypes in the early tumor microenvironment.
To explore therapeutic strategies targeting microglia for early intervention against brain metastasis.

Main Methods:

In vivo fate mapping and time-lapse imaging to track tumor cells and microglia.
Single-cell RNA sequencing to analyze microglial transcriptional heterogeneity.
Opto-omics (holographic photoconversion) for precise spatiotemporal manipulation.
Genetic and pharmacological interventions to perturb microglial responses.

Main Results:

Microglia exhibited significant transcriptional and morphological heterogeneity, with distinct pro- and anti-tumor subsets identified.
Inhibiting transforming growth factor-beta (TGF-β) signaling altered microglial phenotypes.
Deleting tumor cell surface antigens CD24a and CD47 modulated microglial states.
Early microglial responses show plasticity that can be therapeutically targeted.

Conclusions:

Microglial heterogeneity plays a critical role in the early stages of brain metastasis.
Targeting TGF-β signaling or specific tumor antigens can reprogram microglia towards an anti-tumor state.
Harnessing pro-phagocytic microglial functions presents a potential therapeutic window for early brain metastasis intervention.